Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Waltham, Mass.-based Bioverativ will purchase True North Therapeutics, a San Francisco-based biotech, for $400 million, reports Boston Globe.
The Food and Drug Administration on Tuesday approved a new use for Merck's best-selling cancer drug, Keytruda, based on a patient's individual genetic makeup, rather than the physical location of the tumor, reports Reuters.
Newly-merged healthcare organizations can generate significant revenue through various pharmacy-related solutions, according to Alex Minkoff, senior director of health systems strategy at AmerisourceBergen.
Some of the most expensive medications on the market treat a rare disease or cancer, and often represent the first approved treatment for the condition, according to a study from Waltham, Mass.–based life science consulting firm Trinity Partners.
An intriguing discrepancy stood out in our recent survey of 400 hospital stakeholders.
Scott Nelson, Senior Vice President of Supply Chain, Cardinal Health
The Food and Drug Administration on Monday expanded the approved use of Roche's arthritis drug, Actemra.
Cook Medical on May 16 received clearance from the Food and Drug Administration for its Flourish Pediatric Esophageal Atresia device.
The healthcare technology company Philips will purchase St. Paul, Minn.-based RespirTech for an undisclosed amount, reports StarTrbune.
The Food and Drug Administration on Monday approved Sanofi and Regeneron Pharmaceutical's biologic drug Kevzara.
New York state in April enacted new laws to address high drug costs as part of the state's budget, reports Kaiser Health News.